Earnings Feed
Start Free
Vir Biotechnology, Inc.·4

Feb 25, 3:41 PM ET

O'Byrne Jason 4

4 · Vir Biotechnology, Inc. · Filed Feb 25, 2025

Insider Transaction Report

Form 4
Period: 2025-02-22
Vir Biotechnology, Inc.VIR
O'Byrne Jason
EVP & Chief Financial Officer
Transactions
  • Award

    Common Stock

    2025-02-22+40,000→ 115,000 total
  • Award

    Stock Option (Right to Buy)

    2025-02-22+80,000→ 80,000 total
    Exercise: $9.57Exp: 2035-02-21→ Common Stock (80,000 underlying)
Footnotes (2)
  • [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
  • [F2]25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter.

Documents

3 files